No one wants to think about intellectual property rights when a global viral pandemic is marching across the world. But as the urgency for testing kits, ventilators, treatments and vaccines grows, patent rights are already being raised as a potential stumbling block in the U.S. fight against coronavirus (COVID-19). They don’t have to be.To the contrary, the international patent system gives the U.S. the additional tools to fight this exponentially deadly pandemic. But we need to take advantage of what that system offers …